Technology Opportunities

BGN (42)
BioRap (8)
BIRAD (5)
Mor (5)
Ramot (70)
Technion (25)
Tel Hashomer (13)
Yeda (42)
Yissum (38)
Refine / Revise Search248 technologies found
page 3 of 13
BBS (? secretase Blocking Site) Ab -A novel target for Alzheimer's and ALS immunotherapy (Ramot)
THE TECHNOLOGYBBS is a monoclonal antibody that binds specifically and blocks beta-secretase (BACE1) cleavage site on its substrate, APP. BBS inhibits Ab production, a hall-mark of AD and other neurodegenerative diseases such as ALS.The mechanism of action of BBS is based on binding of the ...
Scientific Contact: Beka Solomon
More Details...
Behavioral Animal Models (Ramot)
Laboratory of Biological Psychiatry & Behavioral research- Felsenstein Institute Main Research Topics Cognition, Memory, Social behavior, Motility. Disease: Schizophrenia, Anxiety, Neuropathy pain and Depression Drug Development: Schizophrenia, Depression, Cognition, Pain . Lab facilities ...
Scientific Contact: Irit Gil-Ad
More Details...
BENoC-bus enhancement network on chip (Technion)
Network on chip (NoC) is the future of VLSI interconnects. The technology enables improved chip performance in numerous aspects such as power consumption and data transfer rate. Several drawbacks are to be worked out to accelerate its acceptance as an industry standard. Our technology solves some ...
More Details...
Bert Strassburger Lipid Center, Sheba,Tel Hashomer (Ramot)
Fatty Acid Metabolism and Desaturase enzymes, Cholesterol Metabolism and involved enzymes, Membrane composition and liposomes. The lab focuses on techniques for Lipid analysis, like total lipid quantification and analysis of lipid species like fatty acids, triglycerides, phospholipids,etc. ...
Scientific Contact: Alicia Leikin-Frenkel
More Details...
BioGAL - Novel use of Erythropoietin (EPO) for the treatment of Multiple Myeloma (Mor)
Background MM is a severe and incurable plasma cell malignancy and the second most common blood cancer. The median survival of untreated patients is approximately 10 months. Aggressive chemotherapy may prolong life to an average of 15-40 months. No cure has been found for MM. There is an unmet ...
Scientific Contact: Moshe Mittelman
More Details...
Biological Treatment for Pancreatic Cancer (MMP7 mAb) (Yeda)
Summary The innovative concept leading to this high selectivity is immunization with both a synthetic metal-protein mimicry molecule, previously developed by the present inventors, followed by the metalloenzyme itself (e.g. MMP-7). The resulting antibody exhibits exceptional degree of specificity ...
Scientific Contact: Irit Sagi
More Details...
Biomarkers for risk assessment in colorectal cancer patients (Ramot)
TechnologyWe have developed an ELISA-based immunoassay that measures the levels of two proteins in the blood, Mortalin/GRP75 and HSP70, identifying colorectal cancer patients at high risk of poor survival.Mortalin/GRP75, is a ubiquitous mitochondrial chaperone related to the cytosolic heat ...
Scientific Contact: Zvi Fishelson
More Details...
BiPS for the treatment of Diabetes (Ramot)
Additional information can be provided upon ...
Scientific Contact: Shimon Efrat
More Details...
Brain Injury Animal Models (Ramot)
Blast Brain Injury: a combat zone-like mouse model. From the experimental lab to the war against terror and back to the lab. Improvised explosive devices (IEDs) are one of the main causes for casualties among civilians and military personnel in the present war against terror. IEDs induce ...
Scientific Contact: Chaim G. Pick
More Details...
Buccal Sustained Delivery in a Form of a Sticker for Treatment of Oral Cavity Disorders (Yissum)
Additional information will be provided upon ...
Scientific Contact: Abraham Domb
More Details...
Cardiovascular and Physiological Assessment in Animal Models (Ramot)
Neufeld Cardiac Research Institute at Sheba Medical Center, Tel-Aviv University comprises a fully equipped laboratory to conduct cardiovascular and physiological experiments in small (mice, rat) and large animals (swine, sheep, calf) including heart function studies with special ...
Scientific Contact: Jonathan Leor
More Details...
Cardiovascular Engineering (Ramot)
Department of Biomedical Engineering - Prof. Ofer Barnea Ofer Barnea is a Professor of Biomedical Engineering at Tel Aviv University and is the Director of the Ela Kodesz Institute for Biomedical Physics and Engineering. He was the chairman of the Department of Biomedical Engineering and the ...
Scientific Contact: Ofer Barnea
More Details...
Cardiovascular Testing and Measurements (Ramot)
The general goal of our laboratory is to research design and build in vitro systems that simulate cardiovascular flows, hemodynamic shear forces, and blood-tissue interaction. In addition, the laboratory conducts a wide program of numerical bio-simulations. Focus In Vitro Biological Flows. ...
Scientific Contact: Shmuel Einav
More Details...
Casein micelles for encapsulation of hydrophobic compounds (Technion)
The present technology presents a novel harness casein-micelles (CM), which are natural nanocapsules of essential nutrients for the neonate, by incorporating nutraceuticals in their ...
More Details...
Casein particles encapsulating therapeutically active agents. (Technion)
The present technology describes a novel oral drug delivery system for drug resistance gastric cancers. Comprising a hydrophobic chemotherapeutic drug and a chemosensitizer entrapped within nanoparticles of beta casein (β-CN), which self-associates into micelles. ...
More Details...
CD84 - a Novel Regulator of B-CLL Survival (Yeda)
Summary Chronic lymphocytic leukemia (CLL), a malignant disease characterized by the accumulation of B lymphocytes in the blood, lymphoid organs, and bone marrow, is the second most common type of leukemia in adults, accounting for about 7,000 new cases of leukemia each year. Presently, there is no ...
Scientific Contact: Idit Shachar
More Details...
Cell manipulation using nanoparticles and short laser pulses (Technion)
The present technology involves the use of nanoparticles and laser light to manipulate selected cells for cancer therapy, tissue regeneration and drug ...
More Details...
Cell Therapy for Diabetes: Expansion and re-differentiation of adult human pancreatic islet cells for transplantation (Ramot)
The insulin-producing pancreatic islet β cells are destroyed in type 1 diabetes (T1D) by autoimmunity, and malfunction in type 2 diabetes (T2D), which together afflict >5% of world population. Restoration of a functional β-cell mass by regeneration or transplantation represents the ...
Scientific Contact: Shimon Efrat
More Details...
Cell Therapy to Neurodegenerative Diseases (BGN)
Scientific Contact: Alon Monsonego
More Details...
Cells containing a nanopatch sensor in their membrane (BGN)
Scientific Contact: Jelinek Raz
More Details...
ITTN's partners are affiliated with some of the world's leading Educational and Research Institutions.